Alfasigma USA, Inc.
Advertisement
Articles by Alfasigma USA, Inc.
Advertisement
Latest Updated Articles
Improving Response in Antidepressant Therapy: Focus on Deplin®November 10th 2021
Advertisement
Advertisement
Trending on Psychiatric Times
1
When Treatment-Resistant Depression Means Mismatched: Rethinking Difficult-to-Treat Depression
2
GLP-1 Receptor Agonists Linked to Lower Mortality, Cardiovascular Events in Serious Mental Illness
3
August 2026 in Review: Updates on the Psychiatric Treatment Pipeline, FDA News
4
Ethics and AI Use in Medical Practice: American College of Physicians Releases Position Statement
5